Cardiovascular Effectiveness of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Routine Care of Frail People with Type 2 Diabetes

被引：0
|
作者：
Kutz, Alexander
Gopalakrishnan, Chandrasekar
Kim, Dae H.
Patorno, Elisabetta
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-1082-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1082-P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] IMPACT OF GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS ON BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Timkina, N.
    Simanenkova, A.
    Mart'Yanova, M.
    Karonova, L.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S460 - S460
  • [22] Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists
    Prattichizzo, Francesco
    Candia, Paola de
    Ceriello, Antonio
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 120
  • [23] Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes
    Neuen, Brendon L.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (08) : 709 - 711
  • [24] Choosing GLP-1 receptor agonists or SGLT-2 inhibitors by cardiorenal risk
    Bailey, Clifford J.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (02): : 97 - 99
  • [25] Effects of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Heart Transplant Patients with Type 2 Diabetes: a Case Series
    Sammour, Yasser
    Nassif, Michael
    Thomas, Merrill
    Magwire, Melissa
    Khumri, Taiyeb
    Sperry, Brett
    Austin, Bethany
    Fendler, Timothy
    Kao, Andrew
    Vodnala, Deepthi
    Lawhorn, Stephanie
    Everley, Mark
    Magalski, Anthony
    Kosiborod, Mikhail
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S26 - S26
  • [26] SGLT2 Inhibitors or GLP-1 Receptor Agonists Reduce Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Shaughnessy, Allen F.
    AMERICAN FAMILY PHYSICIAN, 2021, 104 (02) : 206 - 206
  • [27] GLP-1 receptor agonists and SGLT-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients
    Zheng, K.
    Azhie, A.
    You, X.
    Naghibzadeh, M.
    Tan, E.
    Naimimohasses, S.
    Sridhar, V.
    Gupta, S.
    Chen, S.
    Dash, S.
    Jaeckel, E.
    Woo, M.
    Singh, S.
    Cherney, D.
    Bhat, M.
    LIVER TRANSPLANTATION, 2024, 30 : 42 - 42
  • [28] Type 1 diabetes: Prescription of GLP-1 receptor agonists and SGLT2 inhibitors
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2025, 20 (01) : 23 - 23
  • [29] Impact of GLP-1 receptor agonists versus SGLT-2 inhibitors on diabetic retinopathy
    Joo, Julia
    Sharma, Neha
    Daugirdas, Sarunas
    Wu, Anna K.
    Russell, Matthew W.
    Skugor, Mario
    Singh, Rishi
    Rachitskaya, Aleksandra V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [30] Exploring nontraditional cardiorenal advantages of SGLT-2 inhibitors and GLP-1 receptor agonists
    Chen, Jia-Jin
    Lee, Tao-Han
    Yang, Huang-Yu
    KIDNEY INTERNATIONAL, 2024, 105 (03) : 442 - 444
12345